JP2024532964A5 - - Google Patents

Info

Publication number
JP2024532964A5
JP2024532964A5 JP2024500491A JP2024500491A JP2024532964A5 JP 2024532964 A5 JP2024532964 A5 JP 2024532964A5 JP 2024500491 A JP2024500491 A JP 2024500491A JP 2024500491 A JP2024500491 A JP 2024500491A JP 2024532964 A5 JP2024532964 A5 JP 2024532964A5
Authority
JP
Japan
Prior art keywords
methyl
moe
oligonucleotide
nucleoside
complex according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024500491A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024532964A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/073536 external-priority patent/WO2023283620A1/en
Publication of JP2024532964A publication Critical patent/JP2024532964A/ja
Publication of JP2024532964A5 publication Critical patent/JP2024532964A5/ja
Pending legal-status Critical Current

Links

JP2024500491A 2022-03-04 2022-07-08 筋標的化複合体および筋緊張性ジストロフィーを処置するためのその使用 Pending JP2024532964A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263316905P 2022-03-04 2022-03-04
US63/316,905 2022-03-04
PCT/US2022/073536 WO2023283620A1 (en) 2021-07-09 2022-07-08 Muscle targeting complexes and uses thereof for treating myotonic dystrophy

Publications (2)

Publication Number Publication Date
JP2024532964A JP2024532964A (ja) 2024-09-11
JP2024532964A5 true JP2024532964A5 (enExample) 2025-07-15

Family

ID=91603709

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024500491A Pending JP2024532964A (ja) 2022-03-04 2022-07-08 筋標的化複合体および筋緊張性ジストロフィーを処置するためのその使用

Country Status (2)

Country Link
JP (1) JP2024532964A (enExample)
CN (1) CN118265724A (enExample)

Similar Documents

Publication Publication Date Title
JP2024503609A5 (enExample)
IL309910A (en) Muscle targeting complexes and their uses for the treatment of myotonic dystrophy
JP2024524222A5 (enExample)
JP2025512468A5 (enExample)
JP2023510350A5 (enExample)
JP2023509793A5 (enExample)
JP2023510351A5 (enExample)
US20260069704A1 (en) Muscle targeting complexes and formulations for treating myotonic dystrophy
JP2023512441A5 (enExample)
US20250249116A1 (en) Muscle targeting complexes and uses thereof for treating myotonic dystrophy
JP2024501872A5 (enExample)
CN110753756B (zh) 免疫调节性多核苷酸及其应用
JP2023535078A5 (enExample)
JP2025512469A5 (enExample)
JP2024525611A5 (enExample)
CN115427458A (zh) 转谷氨酰胺酶介导的缀合
JP2024534488A5 (enExample)
IL312170A (en) Muscle targeting complexes for treating facioscapulohumeral muscular dystrophy
JP2021532831A5 (enExample)
JP2021533199A5 (enExample)
IL316206A (en) Dosage of muscle targeting complexes for the treatment of myotonic dystrophy
JP2024525612A5 (enExample)
JP2024546436A5 (enExample)
CN107428813A (zh) 组合肿瘤免疫疗法
JP2026503873A (ja) Ｄｍｄ遺伝子のエクソン４５をスキップするための筋肉標的化複合体およびその使用